B9CD15C7-5024-43A4-9214-F7DC07FB5259MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and TherapeuticsResearch GrantMR/N025989/1C008C651-F5B0-4859-A334-5F574AB6B57CMRCINCOME_ACTUAL17997162BEB07A8-A9B2-4D81-BC97-2ACAD5026A3DLenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trialHaematologica1e63125a60411197ad2ebb6c3e6234c7Andrew R. Pettitt2020-01-01http://dx.doi.org/10.3324/haematol.2019.23080532054653http://ukpmc.ac.uk/abstract/MED/320546530390-6078http://europepmc.org/abstract/MED/3205465312Journal Article/Review5f526014b886a6.87907379